GGrantIndex
Sort

326,823 grants matching clinical trial

Discovery and Development of Therapeutic Genes for CHF

$2,972,180
H. Kirk Hammond · Veterans Medical Research Fdn/San Diego · P01 · FY2013 · HL

Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)

$2,972,035
Lorenzo Leggio · National Institute On Drug Abuse · ZIA · FY2023 · DA

Targeting Replication Stress and DNA Damage Response in Uterine Cancer

$2,971,802
Ursula Anne Matulonis · Dana-Farber Cancer Inst · P01 · FY2024 · CA

Intercollaborative Radiation Countermeasure (INTERACT) Consortium for Advanced Development of Medical Countermeasures to Mitigate/Treat Acute and Delayed Radiation Syndromes

$2,971,749
France Carrier · University Of Maryland Baltimore · U19 · FY2023 · AI

Emory Alzheimer's Disease Research Center

$2,971,721
Allan I Levey · Emory University · P30 · FY2021 · AG

Novel Medication Approaches for Substance Abuse

$2,971,695
New York State Psychiatric Institute · P50 · FY2005 · DA

Understanding Papillomavirus Virion Proteins and Vaccines

$2,971,195
John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

A Multi-Site Randomized Study of Intensive Treatment for Toddlers with Autism

$2,971,125
Sally J Rogers · University Of California At Davis · R01 · FY2008 · MH

Field Administration of Stroke Therapy-Magnesium Trial (FAST-MAG)

$2,971,006
Jeffrey L Saver · University Of California Los Angeles · U01 · FY2011 · NS

Novel Therapies to Improve Renal and Cardiac Allograft Outcomes

$2,970,192
Mohamed H Sayegh · Brigham And Women'S Hospital · U01 · FY2012 · AI

Southeast Clinical Oncology Research Consortium, Inc. (SCOR)

$2,970,190
James Norman Atkins · Southeast Clinical Oncol Res Consortium · UG1 · FY2017 · CA

Somatic Truncation Mutations of the Histone Methyltransferase MLL4 Alter Its Subcellular Localization in Bladder Cancer: Mechanistic Insight and Targeted Therapeutic Approach

$2,970,010
Ali Shilatifard · Northwestern University At Chicago · R01 · FY2025 · CA

PACTTE-Partnership for Anemia: Clinical and Translational Trials in the Elderly

$2,969,937
Harvey Jay Cohen · Duke University · U01 · FY2010 · AG

Alabama-Clinical Trials Unit

$2,969,781
Michael S. Saag · University Of Alabama At Birmingham · U01 · FY2011 · AI

Plasticity-Based Adaptive Cognitive Remediation for Schizophrenia

$2,969,780
Henry Wiltshire Mahncke · Brain Plasticity, Inc. · RC3 · FY2010 · MH

Center for Precision Medicine in Leukemia (CPML)

$2,969,744
Mary V. Relling · St. Jude Children'S Research Hospital · P50 · FY2016 · GM

SPORE IN OVARIAN CANCER

$2,969,507
Fox Chase Cancer Center · P50 · FY2001 · CA

Alzheimer's Disease Research Center

$2,969,487
Thomas J. Grabowski · University Of Washington · P50 · FY2015 · AG

Alzheimer's Disease Research Center

$2,969,448
Douglas R Galasko · University Of California, San Diego · P50 · FY2010 · AG

Novel Adenovirus Vector-Based Vaccines for HIV-1

$2,969,378
Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2009 · AI

MECHANISMS AND TREATMENT OF COPD PROGRESSION

$2,969,335
Robert A. Wise · Johns Hopkins University · P50 · FY2007 · HL

Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)

$2,969,015
David S Stephens · Emory University · UM1 · FY2022 · AI

National Transdisciplinary Collaborative Center for African American Men's Health

$2,968,806
Selwyn M Vickers · University Of Alabama At Birmingham · U54 · FY2014 · MD

COORDINATION, MONITORING, FOLLOW-UP, AND EVALUATION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION

$2,968,765
Clint Dart · Health Decisions, Inc. · N01 · FY2023 · HD

Targets to Therapeutics in Pancreatic Cancer

$2,968,687
Daniel D Von Hoff · Translational Genomics Research Inst · P01 · FY2008 · CA